Agile Therapeutics Inc ROCE
¿Qué es el ROCE de Agile Therapeutics Inc?
El ROCE de Agile Therapeutics Inc es 124.01%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Agile Therapeutics Inc
¿Qué hace Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Empresas con roce similar a Agile Therapeutics Inc
- Gridsum Inc tiene ROCE de 120.20%
- Troy Resources tiene ROCE de 120.84%
- Youdao tiene ROCE de 121.94%
- Redhill Biopharma tiene ROCE de 123.00%
- Mountain Crest Acquisition Corp tiene ROCE de 123.33%
- Guardian Exploration tiene ROCE de 123.73%
- Agile Therapeutics Inc tiene ROCE de 124.01%
- Amarillo Biosciences tiene ROCE de 124.14%
- Plus Therapeutics tiene ROCE de 125.08%
- Trend Innovations tiene ROCE de 125.59%
- Quest Water Global tiene ROCE de 129.00%
- Kiadis Pharma N.V tiene ROCE de 129.18%
- Plymouth Realty Capital tiene ROCE de 130.50%